Correction to: A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an NKCC1 Inhibitor, in Patients with Drug-Resistant Epilepsy

Zeinab Gharaylou; Abbas Tafakhori; Elmira Agah; Vajiheh Aghamollaii; Abbas Kebriaeezadeh; Mahmoudreza Hadjighassem

doi:10.1007/s40263-019-00653-z

Correction to: A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an NKCC1 Inhibitor, in Patients with Drug-Resistant Epilepsy

CNS Drugs. 2019 Aug;33(8):839. doi: 10.1007/s40263-019-00653-z.

Authors

Zeinab Gharaylou¹, Abbas Tafakhori², Elmira Agah^{3

4}, Vajiheh Aghamollaii⁵, Abbas Kebriaeezadeh⁶, Mahmoudreza Hadjighassem^{7

8}

Affiliations

¹ Department of Neuroscience and Addiction Study, School of Advanced Technologies in Medicine, International Campus, Tehran University of Medical Sciences, Tehran, Iran.
² Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
³ Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.
⁴ NeuroImmunology Research Association (NIRA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
⁵ Department of Neurology, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran, Iran.
⁶ Pharmaceutical Management and Economic Research Center, Tehran University of Medical Sciences, Tehran, Iran.
⁷ Department of Neuroscience and Addiction Study, School of Advanced Technologies in Medicine, International Campus, Tehran University of Medical Sciences, Tehran, Iran. mhadjighassem@tums.ac.ir.
⁸ Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran. mhadjighassem@tums.ac.ir.

PMID: 31338793
DOI: 10.1007/s40263-019-00653-z

Abstract

The correct name of the co-author should be ''Vajiheh Aghamollaii'', and not ''Vajihe Aghamollaii'' as given in the original publication of the article.

Publication types

Published Erratum